Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa (NCT04708015) | Clinical Trial Compass
CompletedNot Applicable
Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa
United States, Netherlands15 participantsStarted 2020-11-05
Plain-language summary
The primary objective of this study is to assess the percentage of time patients were in normal glucose control.
Who can participate
Age range8 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of GSDIa confirmed by either liver biopsy or molecular testing.
* Currently using the Dexcom G6 iCGM for glycemic control and with approximately one (1) month of CGM data available on the Dexcom Clarity cloud and have authorized sharing of data with thereferral center through the Dexcom Clarity app.
Exclusion Criteria:
* Presence or history of any disease, condition or chronic medication that, in the Investigator's opinion, would significantly affect interpretation of study results.
* Use of any investigational product or investigational medical device within 30 calendar days preceding screening or before completion of all scheduled study assessments during study enrollment.
What they're measuring
1
Percentage of time spent in normal glucose control (defined as glucose levels between 70 mg/dL - 120 mg/dL) over a seven-day period